{"title":"Overcoming Barriers to Diabetes Technology in Youth with Type 1 Diabetes and Public Insurance: Cases and Call to Action","authors":"Ming Yeh Lee, M. Tanenbaum, D. Maahs, P. Prahalad","doi":"10.1155/2022/9911736","DOIUrl":null,"url":null,"abstract":"Advancements in diabetes technology such as continuous glucose monitoring (CGM), insulin pumps, and automated insulin delivery provide opportunities to improve glycemic control for youth with type 1 diabetes (T1D). However, diabetes technology use is lower in youth on public insurance, and this technology use gap is widening in the US. There is a significant need to develop effective interventions and policies to promote equitable care. The dual purpose of this case series is as follows: (1) describe success stories of the CGM Time in Range Program (CGM TIPs), which removed barriers for initiating CGM and provided asynchronous remote glucose monitoring for youth on public insurance, and (2) advocate for improving CGM coverage by public insurance. We describe a series of six youths with T1D and public insurance who obtained and sustained use of CGM with assistance from the program. Three youths had improved engagement with the care team while on CGM and the remote monitoring protocol, and three youths were able to leverage sustained CGM wear to obtain insurance coverage for automated insulin delivery systems. CGM TIPs helped these youths achieve lower hemoglobin A1c and improved time in range (TIR). Despite the successes, expansion of CGM TIPs is limited by stringent barriers for CGM approval and difficult postapproval patient workflows to receive shipments. These cases highlight the potential for combining diabetes technology and asynchronous remote monitoring to support continued use and provide education to improve glycemic control for youth with T1D on public insurance and the need to reduce barriers for obtaining CGM coverage by public insurance.","PeriodicalId":9621,"journal":{"name":"Case Reports in Endocrinology","volume":"38 1","pages":""},"PeriodicalIF":0.9000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2022/9911736","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 2
Abstract
Advancements in diabetes technology such as continuous glucose monitoring (CGM), insulin pumps, and automated insulin delivery provide opportunities to improve glycemic control for youth with type 1 diabetes (T1D). However, diabetes technology use is lower in youth on public insurance, and this technology use gap is widening in the US. There is a significant need to develop effective interventions and policies to promote equitable care. The dual purpose of this case series is as follows: (1) describe success stories of the CGM Time in Range Program (CGM TIPs), which removed barriers for initiating CGM and provided asynchronous remote glucose monitoring for youth on public insurance, and (2) advocate for improving CGM coverage by public insurance. We describe a series of six youths with T1D and public insurance who obtained and sustained use of CGM with assistance from the program. Three youths had improved engagement with the care team while on CGM and the remote monitoring protocol, and three youths were able to leverage sustained CGM wear to obtain insurance coverage for automated insulin delivery systems. CGM TIPs helped these youths achieve lower hemoglobin A1c and improved time in range (TIR). Despite the successes, expansion of CGM TIPs is limited by stringent barriers for CGM approval and difficult postapproval patient workflows to receive shipments. These cases highlight the potential for combining diabetes technology and asynchronous remote monitoring to support continued use and provide education to improve glycemic control for youth with T1D on public insurance and the need to reduce barriers for obtaining CGM coverage by public insurance.
糖尿病技术的进步,如连续血糖监测(CGM)、胰岛素泵和自动胰岛素输送,为改善青少年1型糖尿病(T1D)的血糖控制提供了机会。然而,在接受公共保险的年轻人中,糖尿病技术的使用较低,而且这种技术使用差距在美国正在扩大。迫切需要制定有效的干预措施和政策,以促进公平护理。本案例系列的双重目的是:(1)描述CGM Time in Range Program (CGM TIPs)的成功案例,该项目消除了启动CGM的障碍,为公共保险青年提供异步远程血糖监测;(2)倡导公共保险提高CGM的覆盖率。我们描述了一系列六名患有T1D和公共保险的年轻人,他们在该计划的帮助下获得并持续使用CGM。三名年轻人在使用CGM和远程监测方案时改善了与护理团队的接触,三名年轻人能够利用持续佩戴CGM来获得自动胰岛素输送系统的保险。CGM TIPs帮助这些年轻人实现了较低的血红蛋白A1c,并改善了范围内时间(TIR)。尽管取得了成功,但CGM TIPs的扩展受到CGM批准的严格障碍和批准后患者接收货物的困难工作流程的限制。这些案例强调了将糖尿病技术与异步远程监测相结合的潜力,以支持继续使用,并提供教育,以改善公共保险中患有糖尿病的青年的血糖控制,以及减少通过公共保险获得糖尿病保险的障碍的必要性。